Format

Send to

Choose Destination
See comment in PubMed Commons below
Diabetes Metab Syndr. 2013 Jan-Mar;7(1):1-2. doi: 10.1016/j.dsx.2013.02.028. Epub 2013 Mar 9.

Botulinum toxin for meralgia paresthetica in type 2 diabetes.

Author information

1
Department of Neurology, Command Hospital, Bangalore, India.

Abstract

Botulinum toxin has been used for a variety of neuropathic conditions in diabetes mellitus. Meralgia paresthetica is a mononeuropathy of femoral nerve seen in diabetes and obesity with an unclear etiopathogenesis. We studied the role of botulinum toxin in resistant cases of meralgia paresthetica in type 2 diabetes.

PMID:
23517786
DOI:
10.1016/j.dsx.2013.02.028
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center